REQUIRED FIELDS ARE MARKED IN BOLD. PLEASE NOTE THAT MISSING INFORMATION WILL DELAY OUR ABILITY TO ASSIST YOU IN ACCESSING SUPPORT
			
			
      
		
		
		
		
		
		
		
		
		
		
		
		
			Vivimusta® (bendamustine HCl) injection 100 mg/4 mL (25 mg/mL) multi-dose vial
			
			
			
		 
		
		
      By signing below, I certify that (1) the above therapy is medically necessary and in the best interest of the patient listed above; (2) the information provided is complete
				and accurate to the best of my knowledge; (3) I have obtained any and all authorizations and consents from the patient or the patient’s authorized personal representative necessary under HIPAA and state
				law to release protected health information, including that contained on this form, to Azurity Pharmaceuticals and its affiliates, vendors, and agents for purposes relating to the Vivimusta CONNECT® Program,
				to solely assist with benefits verification, prior authorization/appeals assistance, and forwarding the above prescription by fax or other means of delivery to a licensed pharmacy to dispense Vivimusta® where
				appropriate; and (4) I agree to the Business Associate Agreement as presented at https://baa.vivimustaconnect.com/.